genetic mutation

Merck hands over $20M in IBD target deal with Quotient

After generating interest from Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co.

Fraiser Kansteiner Mar 24, 2026 6:00am

Blocking enzyme saved mice from known Parkinson’s mechanism

Jul 2, 2025 5:26pm

CRISPR solves mystery of why cancer cells have extra chromosomes

Jul 7, 2023 10:40am

Does the special dog-human bond extend to cancer genes?

Jul 6, 2023 3:45pm

Merck taps Illumina’s genomic tests to spot cancer mutations

Sep 8, 2021 9:10am

Vanderbilt team offers new clues for targeting p53

Sep 1, 2021 9:50am